John Orwin

Board Chairman of Anaptys
CEO of Atreca

John Orwin has served as a member and Chairman of our board of directors since September 2023. Mr. Orwin has been served as President and Chief Executive of Officer of Atreca, Inc. since from April 2018 to June 2024. He also has served as a member of the board of directors of CARGO Therapeutics, Inc. since August 2022, and Travere Therapeutics, Inc. since March 2017.

Additionally, Mr. Orwin currently serves as the Chair of the Board of Directors of the privately held company Nested Therapeutics, on the Board of Directors of the privately held company Ambrosia Biosciences, Inc., and as the Executive Chair of the Board of Directors of the privately held company Agni Bio, Inc., and is a Venture Partner in Samsara BioCapital. He previously served as a member of the board of directors of Seagen, Inc. since January 2014 until its acquisition by Pfizer in December 2023 and Array BioPharma, Inc. from November 2012 to July 2019.

Mr. Orwin received a BA in Economics from Rutgers, The State University of New Jersey and a MBA from New York University. Our board of directors believes that Mr. Orwin’s extensive industry experience and executive positions at multiple biopharmaceutical companies qualify him to serve on our board of directors.